Prioritizing oral bioavailability in drug development strategies

Future Med Chem. 2024 Dec 26:1-3. doi: 10.1080/17568919.2024.2444871. Online ahead of print.

Authors

Lijuan Xie¹, Yingjing Hong¹, Yun Hu¹, Hongmei Li¹, Jie Lou¹, Xing Zhou²

Affiliations

¹ School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, PR China.
² Yunnan Key Laboratory of Stem Cell and Regenerative Medicine & School of Rehabilitation, Kunming Medical University, Kunming, PR China.

PMID: 39723437
DOI: 10.1080/17568919.2024.2444871

No abstract available

Keywords: Absorption enhancers; Formulation design; Molecular modifications; Oral Bioavailability; Oral drug delivery.

Publication types

Editorial